Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs and Classical and Selective Cyclooxygenase-2 Inhibitors: A Meta-analysis of Observational Studies.

Martín Arias LH, Martín González A, Sanz Fadrique R, Vazquez ES.

J Clin Pharmacol. 2019 Jan;59(1):55-73. doi: 10.1002/jcph.1302. Epub 2018 Sep 11.

PMID:
30204233
2.

Heme Oxygenase-1 protects astroglia against manganese-induced oxidative injury by regulating mitochondrial quality control.

Gorojod RM, Alaimo A, Porte Alcon S, Martinez JH, Cortina ME, Vazquez ES, Kotler ML.

Toxicol Lett. 2018 Oct 1;295:357-368. doi: 10.1016/j.toxlet.2018.07.045. Epub 2018 Jul 21.

PMID:
30040983
3.

In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development.

Jaworski FM, Gentilini LD, Gueron G, Meiss RP, Ortiz EG, Berguer PM, Ahmed A, Navone N, Rabinovich GA, Compagno D, Laderach DJ, Vazquez ES.

Clin Cancer Res. 2017 Sep 1;23(17):5135-5148. doi: 10.1158/1078-0432.CCR-17-0112. Epub 2017 May 16.

4.

Heme oxygenase-1 in the forefront of a multi-molecular network that governs cell-cell contacts and filopodia-induced zippering in prostate cancer.

Paez AV, Pallavicini C, Schuster F, Valacco MP, Giudice J, Ortiz EG, Anselmino N, Labanca E, Binaghi M, Salierno M, Martí MA, Cotignola JH, Woloszynska-Read A, Bruno L, Levi V, Navone N, Vazquez ES, Gueron G.

Cell Death Dis. 2016 Dec 29;7(12):e2570. doi: 10.1038/cddis.2016.420.

5.

CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs.

De Luca P, Dalton GN, Scalise GD, Moiola CP, Porretti J, Massillo C, Kordon E, Gardner K, Zalazar F, Flumian C, Todaro L, Vazquez ES, Meiss R, De Siervi A.

Oncotarget. 2016 Apr 5;7(14):18798-811. doi: 10.18632/oncotarget.7711.

6.

Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases.

Wan X, Corn PG, Yang J, Palanisamy N, Starbuck MW, Efstathiou E, Li Ning Tapia EM, Zurita AJ, Aparicio A, Ravoori MK, Vazquez ES, Robinson DR, Wu YM, Cao X, Iyer MK, McKeehan W, Kundra V, Wang F, Troncoso P, Chinnaiyan AM, Logothetis CJ, Navone NM.

Sci Transl Med. 2014 Sep 3;6(252):252ra122. doi: 10.1126/scitranslmed.3009332. Erratum in: Sci Transl Med. 2015 May 13;7(287):287er3. Tapia, Elsa M Li-Ning [corrected to Li Ning Tapia, Elsa M].

7.

Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice.

Moiola CP, De Luca P, Zalazar F, Cotignola J, Rodríguez-Seguí SA, Gardner K, Meiss R, Vallecorsa P, Pignataro O, Mazza O, Vazquez ES, De Siervi A.

Clin Cancer Res. 2014 Aug 1;20(15):4086-95. doi: 10.1158/1078-0432.CCR-14-0322. Epub 2014 May 19.

8.

BRCA1 and p53 regulate critical prostate cancer pathways.

De Luca P, Moiola CP, Zalazar F, Gardner K, Vazquez ES, De Siervi A.

Prostate Cancer Prostatic Dis. 2013 Sep;16(3):233-8. doi: 10.1038/pcan.2013.12. Epub 2013 May 14.

PMID:
23670255
9.

Activation of β-catenin signaling in androgen receptor-negative prostate cancer cells.

Wan X, Liu J, Lu JF, Tzelepi V, Yang J, Starbuck MW, Diao L, Wang J, Efstathiou E, Vazquez ES, Troncoso P, Maity SN, Navone NM.

Clin Cancer Res. 2012 Feb 1;18(3):726-36. doi: 10.1158/1078-0432.CCR-11-2521.

10.

BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.

De Luca P, Vazquez ES, Moiola CP, Zalazar F, Cotignola J, Gueron G, Gardner K, De Siervi A.

Mol Cancer Res. 2011 Aug;9(8):1078-90. doi: 10.1158/1541-7786.MCR-11-0155. Epub 2011 Jun 23.

11.

Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells.

Gueron G, De Siervi A, Ferrando M, Salierno M, De Luca P, Elguero B, Meiss R, Navone N, Vazquez ES.

Mol Cancer Res. 2009 Nov;7(11):1745-55. doi: 10.1158/1541-7786.MCR-08-0325. Epub 2009 Nov 10.

12.

Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.

Li ZG, Mathew P, Yang J, Starbuck MW, Zurita AJ, Liu J, Sikes C, Multani AS, Efstathiou E, Lopez A, Wang J, Fanning TV, Prieto VG, Kundra V, Vazquez ES, Troncoso P, Raymond AK, Logothetis CJ, Lin SH, Maity S, Navone NM.

J Clin Invest. 2008 Aug;118(8):2697-710. doi: 10.1172/JCI33093.

13.

Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.

Li ZG, Yang J, Vazquez ES, Rose D, Vakar-Lopez F, Mathew P, Lopez A, Logothetis CJ, Lin SH, Navone NM.

Oncogene. 2008 Jan 24;27(5):596-603. Epub 2007 Aug 13.

PMID:
17700537
14.

Homeostatic response under carcinogen withdrawal, heme oxygenase 1 expression and cell cycle association.

Castronuovo CC, Sacca PA, Meiss R, Caballero FA, Batlle A, Vazquez ES.

BMC Cancer. 2006 Dec 14;6:286.

15.

Personalized therapy: an interdisciplinary challenge.

Vazquez ES.

Per Med. 2004 Dec;1(1):127-130. doi: 10.1517/17410541.1.1.127.

PMID:
29793225
16.

p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells.

Martinez LA, Yang J, Vazquez ES, Rodriguez-Vargas Mdel C, Olive M, Hsieh JT, Logothetis CJ, Navone NM.

Carcinogenesis. 2002 Aug;23(8):1289-96.

PMID:
12151346
17.

Delta-aminolevulinic acid cytotoxic effects on human hepatocarcinoma cell lines.

De Siervi A, Vazquez ES, Rezaval C, Rossetti MV, del Batlle AM.

BMC Cancer. 2002 Mar 22;2:6.

18.

Reducing sugars trigger delta-aminolevulinic dehydratase inactivation: evidence of in vitro aspirin prevention.

Caballero FA, Gerez EN, Polo CF, Vazquez ES, Batlle AM.

Gen Pharmacol. 1998 Sep;31(3):441-5.

PMID:
9703216
19.

Griseofulvin-induced hepatopathy due to abnormalities in heme pathway.

Polo CF, Buzaleh AM, Vazquez ES, Afonso SG, Navone NM, Batlle AM.

Gen Pharmacol. 1997 Aug;29(2):207-10.

PMID:
9251900
20.

Effect of chronic anesthesia on the drug-metabolizing enzyme system and heme pathway regulation.

Buzaleh AM, Vazquez ES, Nuñez G, del Carmen Batlle AM.

Gen Pharmacol. 1997 Apr;28(4):577-82.

PMID:
9147027
21.

Alterations in fluorinated ether anesthetics effects on heme metabolism following chronic ethanol consumption.

Buzaleh AM, Vazquez ES, Batlle AM.

Gen Pharmacol. 1995 Oct;26(6):1425-9.

PMID:
7590142
22.

STZ-induced diabetes in mice and heme pathway enzymes. Effect of allylisopropylacetamide and alpha-tocopherol.

Polo CF, Vázquez ES, Gerez EN, Caballero FA, Batlle AM.

Chem Biol Interact. 1995 Apr 14;95(3):327-34.

PMID:
7728901
23.

Heme biosynthesis pathway regulation in a model of hepatocarcinogenesis pre-initiation.

Polo CF, Vazquez ES, Caballero F, Gerez E, Battle AM.

Comp Biochem Physiol B. 1992 Sep;103(1):251-6.

PMID:
1451437
24.

Rhodanese and ALA-S in mammary tumor and liver from normal and tumor-bearing mice.

Navone NM, Vázquez ES, Polo CF, Batlle AM.

Comp Biochem Physiol B. 1992 May;102(1):83-5.

PMID:
1526138
25.

Regulation of heme pathway in regenerating mouse liver.

Polo CF, Vazquez ES, Batlle AM.

Comp Biochem Physiol B. 1992 Jan-Feb;101(1-2):243-6.

PMID:
1499271
26.

The effect of griseofulvin on the heme pathway--II. An exhaustive analysis during short and long-term challenge.

Navone NM, Buzaleh AM, Polo CF, Afonso SG, Vázquez ES, Batlle AM.

Gen Pharmacol. 1991;22(6):1179-83.

PMID:
1810812
27.

In vitro effect of cyanide, thiosulphate and S-adenosyl-L-methionine on the activity of rhodanese and other enzymes.

Buzaleh AM, Vazquez ES, Del Carmen Batlle AM.

Gen Pharmacol. 1991;22(2):281-6.

PMID:
1647344
28.

In vivo prevention and reversal by the antimitotic colchicine and other related compounds of some porphyrinogenic drug action on heme pathway.

Afonso SG, Polo CF, Navone NM, Vazquez ES, Buzaleh AM, Schoua E, Batlle AM.

Gen Pharmacol. 1990;21(4):423-6.

PMID:
2379798
29.

The effect of cyanide intoxication on hepatic rhodanese kinetics.

Buzaleh AM, Vazquez ES, Batlle AM.

Gen Pharmacol. 1990;21(2):219-22.

PMID:
2332141
30.
31.

Cyanide intoxication--III. On the analogous and different effects provoked by non-lethal and lethal challenged doses.

Buzaleh AM, Vazquez ES, del Carmen Batlle AM.

Gen Pharmacol. 1990;21(1):27-32.

PMID:
2153608
32.

Cyanide intoxication. II. The effects of systematic cyanide challenge on indicative toxicity parameters.

Buzaleh AM, Vázquez ES, Batlle AM.

Comp Biochem Physiol C. 1990;96(1):177-80.

PMID:
1980875
33.

Cyanide intoxication--I. An oral chronic animal model.

Buzaleh AM, Vazquez ES, Batlle AM.

Gen Pharmacol. 1989;20(3):323-7.

PMID:
2545508

Supplemental Content

Loading ...
Support Center